secwatch.observer — SEC 8-K summary
======================================

Issuer:     Merck & Co., Inc. (MRK)
CIK:        0000310158
Form:       8-K
Filed at:   2022-10-27T23:59:59+00:00
Accession:  0001104659-22-111729
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Merck Q3 beats: rev $15B, non-GAAP EPS $1.85; raises FY outlook; Davis to become Chairman
--------------------------------------------------------------------------------

- Q3 revenue $15.0B (+14% YoY); GAAP EPS $1.28, non-GAAP EPS $1.85 (+4% from $1.78).
- KEYTRUDA sales $5.4B (+20%), GARDASIL sales $2.3B (+15%); LAGEVRIO contributed $436M.
- Raises FY2022 sales outlook to $58.5-59.0B (growth 20-21%); non-GAAP EPS guidance raised to $7.32-7.37.
- Executive Chairman Kenneth Frazier to retire Nov 30; CEO Robert Davis elected Chairman effective Dec 1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310158/000110465922111729/0001104659-22-111729-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310158/000110465922111729/tm2227726d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-111729

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer